Maureen Prewitt

736 total citations
14 papers, 546 citations indexed

About

Maureen Prewitt is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Maureen Prewitt has authored 14 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 12 papers in Public Health, Environmental and Occupational Health and 6 papers in Oncology. Recurrent topics in Maureen Prewitt's work include Reproductive Biology and Fertility (12 papers), Ovarian function and disorders (9 papers) and Cancer Risks and Factors (6 papers). Maureen Prewitt is often cited by papers focused on Reproductive Biology and Fertility (12 papers), Ovarian function and disorders (9 papers) and Cancer Risks and Factors (6 papers). Maureen Prewitt collaborates with scholars based in United States. Maureen Prewitt's co-authors include Clarisa R. Gracia, Mary D. Sammel, Jill P. Ginsberg, Claire Carlson, Katherine Dillon, Ellen W. Freeman, Dana B. Walker, Jennifer E. Mersereau, Yasmin Gosiengfiao and Laxmi A. Kondapalli and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Human Reproduction and Fertility and Sterility.

In The Last Decade

Maureen Prewitt

14 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen Prewitt United States 11 420 371 114 98 98 14 546
Phoebe Wright United States 7 305 0.7× 360 1.0× 81 0.7× 153 1.6× 147 1.5× 15 590
F. Fischl Austria 10 292 0.7× 277 0.7× 102 0.9× 60 0.6× 65 0.7× 26 449
Robert Ochsenkühn Germany 12 211 0.5× 203 0.5× 177 1.6× 50 0.5× 45 0.5× 19 443
Fiona Bruinsma Australia 3 180 0.4× 264 0.7× 98 0.9× 51 0.5× 78 0.8× 3 390
Marianne J. ten Kate‐Booij Netherlands 9 311 0.7× 150 0.4× 184 1.6× 51 0.5× 14 0.1× 22 451
Hamish Wallace United Kingdom 5 348 0.8× 277 0.7× 124 1.1× 87 0.9× 56 0.6× 8 449
Veerle Vloeberghs Belgium 16 321 0.8× 509 1.4× 176 1.5× 143 1.5× 19 0.2× 30 654
M. Quinn United States 12 196 0.5× 248 0.7× 126 1.1× 21 0.2× 21 0.2× 23 378
J. van Disseldorp Netherlands 6 257 0.6× 340 0.9× 87 0.8× 25 0.3× 25 0.3× 7 492
N. Conte Italy 4 172 0.4× 179 0.5× 86 0.8× 43 0.4× 21 0.2× 5 284

Countries citing papers authored by Maureen Prewitt

Since Specialization
Citations

This map shows the geographic impact of Maureen Prewitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Prewitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Prewitt more than expected).

Fields of papers citing papers by Maureen Prewitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Prewitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Prewitt. The network helps show where Maureen Prewitt may publish in the future.

Co-authorship network of co-authors of Maureen Prewitt

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Prewitt. A scholar is included among the top collaborators of Maureen Prewitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Prewitt. Maureen Prewitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Prewitt, Maureen, et al.. (2021). A predictive model for chemotherapy-related diminished ovarian reserve in reproductive-age women. Fertility and Sterility. 115(2). 431–437. 12 indexed citations
2.
Gracia, Clarisa R., et al.. (2018). Multi-center clinical evaluation of the Access AMH assay to determine AMH levels in reproductive age women during normal menstrual cycles. Journal of Assisted Reproduction and Genetics. 35(5). 777–783. 31 indexed citations
3.
Carlson, Claire, et al.. (2018). Ovarian tissue cryopreservation (OTC) in prepubertal girls and young women: an analysis of parents’ and patients’ decision-making. Journal of Assisted Reproduction and Genetics. 35(4). 593–600. 10 indexed citations
4.
Sammel, Mary D., et al.. (2018). Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan. The Journal of Clinical Endocrinology & Metabolism. 104(5). 1813–1822. 18 indexed citations
5.
Johnson, Lauren, et al.. (2017). Antimüllerian hormone levels are lower in BRCA2 mutation carriers. Fertility and Sterility. 107(5). 1256–1265.e6. 45 indexed citations
6.
Johnson, Lauren, et al.. (2016). Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles. Fertility and Sterility. 106(7). 1793–1799.e2. 3 indexed citations
7.
Sammel, Mary D., et al.. (2016). Impact of chemotherapy on androgen and follicular measures of ovarian reserve in female cancer survivors. Fertility and Sterility. 106(3). e128–e128. 1 indexed citations
8.
Kondapalli, Laxmi A., Katherine Dillon, Mary D. Sammel, et al.. (2013). Quality of life in female cancer survivors: is it related to ovarian reserve?. Quality of Life Research. 23(2). 585–592. 19 indexed citations
9.
Dillon, Katherine, et al.. (2013). Pregnancy after cancer: Results from a prospective cohort study of cancer survivors. Pediatric Blood & Cancer. 60(12). 2001–2006. 32 indexed citations
10.
Gracia, Clarisa R., Christopher B. Morse, Grace Chan, et al.. (2012). Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization. Fertility and Sterility. 97(3). 585–591. 56 indexed citations
11.
McDade, Thomas W., Teresa K. Woodruff, Yuan Huang, et al.. (2012). Quantification of anti-Mullerian hormone (AMH) in dried blood spots: validation of a minimally invasive method for assessing ovarian reserve. Human Reproduction. 27(8). 2503–2508. 24 indexed citations
12.
Gracia, Clarisa R., Jeff Chang, Laxmi A. Kondapalli, et al.. (2012). Ovarian tissue cryopreservation for fertility preservation in cancer patients: Successful establishment and feasibility of a multidisciplinary collaboration. Journal of Assisted Reproduction and Genetics. 29(6). 495–502. 39 indexed citations
13.
Dillon, Katherine, Mary D. Sammel, Maureen Prewitt, et al.. (2012). Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. Fertility and Sterility. 99(2). 477–483.e1. 102 indexed citations
14.
Gracia, Clarisa R., Mary D. Sammel, Ellen W. Freeman, et al.. (2011). Impact of cancer therapies on ovarian reserve. Fertility and Sterility. 97(1). 134–140.e1. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026